The pharmaceutical industry is subject to strict supervision by both national and international authorities that regulate the development, production, approval, and distribution of drugs and medicinal products, based on laws, guidelines, and recommendations. The complexity and diversity of “regulatory affairs“ have steadily increased in the daily operations of pharmaceutical companies due to their need to adapt to EU-wide laws, advancing globalization, and the development of new markets, among other factors.
The University of Bonn offers the master's degree program in continuing education for Drug Regulatory Affairs in collaboration with the German Society for Drug Regulatory Affairs (Deutsche Gesellschaft für Drug Regulatory Affairs e.V., DGRA). This degree program is interdisciplinary, spanning the fields of pharmacy, law, and medicine. It is designed for university graduates with at least one year of relevant work experience who seek to acquire additional, academically well-grounded qualifications to fill a demanding position in a regulatory affairs department or a related field.
